Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Ischemic Heart Disease

Free Subscription 13.07.2026 2 Am Heart J 4 Am J Cardiol 3 Ann Thorac Surg 1 BMJ 1 Catheter Cardiovasc Interv 4 Circulation 3 Clin Cardiol 1 Eur Heart J 1 Heart 3 J Am Coll Cardiol 2 J Cardiovasc Pharmacol 1 J Clin Invest 1 J Mol Cell Cardiol 1 Mol Cell Biochem 2 PLoS One 1 Prog Cardiovasc Dis 2 Thromb Haemost

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. BROYD CJ, Arunothayaraj S, Scheller B, Eccleshall S, et al
   The European bifurcation club randomized trial of stepwise provisional stenting vs drug-coated balloon therapy for nonleft main true coronary bifurcations: The EBC DCB trial.
   Am Heart J. 2026;300:107463.
   PubMed         Abstract available
   
   
2. ANG D, Young R, Taggart D, Carrick D, et al
   International study of Coronary Microvascular Angina (iCorMicA): a registry-based diagnostic study and nested randomized trial.
   Am Heart J. 2026 Jul 6:107527. doi: 10.1016/j.ahj.2026.107527.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

3. JOSEY GC, Cohen J, Scheinuk JE, Hasnie UA, et al
   Sex Differences in Clinical Outcomes Among Patients With Myocarditis-Associated Cardiogenic Shock: A Retrospective Multi-Center Cohort Study.
   Am J Cardiol. 2026;272:156-159.
   PubMed         Abstract available
   
   
4. RU L, Gong Z, Zhao Y, Song X, et al
   Titrated Contrast Recanalization: A Novel Controlled-Contrast Technique for Anterograde Crossing of Chronic Total Occlusion.
   Am J Cardiol. 2026;272:118-124.
   PubMed         Abstract available
   
   
5. TAHA A, Mondal A, Sandhyavenu H, Atti L, et al
   Outcomes of Early Sodium-Glucose Cotransporter Two Inhibitor Use in Takotsubo Syndrome: Insights From a Multicenter Real-World Cohort Study.
   Am J Cardiol. 2026;272:95-102.
   PubMed         Abstract available
   
   
6. NATHAN S, Tosun S, Al-Rameni D, Jezovnik MK, et al
   Left Ventricular Venting Strategies for Cardiogenic Shock in Patients Treated With Extracorporeal Cardiopulmonary Support V-A ECMO: From Left Ventricular Unloading to Offloading.
   Am J Cardiol. 2026;272:42-50.
   PubMed         Abstract available
   
   

   
   Ann Thorac Surg

7. DEFAZIO D, Wei L, Chauhan D, Hayanga JW, et al
   Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention for Stable Multivessel Coronary Disease in the Current Era.
   Ann Thorac Surg. 2026 Jul 7:S0003-4975(26)00712.
   PubMed         Abstract available
   
   
8. MAGRUDER JT, Kim SA, Helmers M, Morris CD, et al
   Impact of preoperative and postoperative modern guideline-directed medical therapy on survival following coronary artery bypass grafting.
   Ann Thorac Surg. 2026 Jul 6:S0003-4975(26)00706.
   PubMed         Abstract available
   
   
9. LODO V, Capozza C, Barbero C, Brenna D, et al
   Does prior percutaneous coronary revascularization negatively affect the outcomes of subsequent coronary artery bypass grafting?
   Ann Thorac Surg. 2026 Jul 4:S0003-4975(26)00705.
   PubMed         Abstract available
   
   

   
   BMJ

10. TORJESEN I
    Most obesity drugs do not improve quality of life or reduce cardiovascular risk, analysis finds.
    BMJ. 2026;394:e100232.
    PubMed        
    
    

    
    Catheter Cardiovasc Interv

11. MA X, Zhang W, Zhang N, Zhong Q, et al
    The High-Sensitivity C-Reactive Protein-Albumin-Lymphocyte Index Is a Prognostic Marker for All-Cause and Cardiovascular Mortality in Patients With ST-Elevation Myocardial Infarction.
    Catheter Cardiovasc Interv. 2026 Jul 10. doi: 10.1002/ccd.70745.
    PubMed         Abstract available
    
    

    
    Circulation

12. XIONG Z, Li Y, Zhang Y, Ma Z, et al
    RND3 Enhances Cardiac Glucose Metabolism Through Inhibiting ACAT1-Dependent PDHA1 Acetylation and Protects Against Ischemia-Reperfusion Injury.
    Circulation. 2026;154:37-57.
    PubMed         Abstract available
    
    
13. ITCHHAPORIA D, Yancy CW, Rosen SE, Mbakwem AC, et al
    Cardiovascular Health Equity: Time for a New Era of Science, Sociology, and Interventions.
    Circulation. 2026 Jul 8. doi: 10.1161/CIR.0000000000001445.
    PubMed        
    
    
14. DIDOMENICO RJ, Marrs JC, Bress AP, Denfeld QE, et al
    Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Jul 8. doi: 10.1161/CIR.0000000000001459.
    PubMed         Abstract available
    
    
15. PIGEYRE M, Gerstein HC
    Cardiovascular Risk Reduction With GLP-1 RA Drugs.
    Circulation. 2026;154:66-73.
    PubMed         Abstract available
    
    

    
    Clin Cardiol

16. MEHMOOD A, Bajwa A
    Comment on Wang et al.: Unaddressed Multiple Comparisons Risk Inflating Type, Error in Cardiovascular Specialty Nursing Research.
    Clin Cardiol. 2026;49:e70409.
    PubMed        
    
    
17. SU H, Liu X
    Associations of the C-Reactive Protein-Albumin-Lymphocyte Index, Red Cell Distribution Width-Albumin Ratio, and Blood Urea Nitrogen-Albumin Ratio With All-Cause and Cardiovascular Mortality Among Adults With Preclinical Heart Failure.
    Clin Cardiol. 2026;49:e70401.
    PubMed         Abstract available
    
    
18. OZ MT, Sahin U, Kaya A
    Does Serum gammaKlotho Truly Provide Incremental Prognostic Value Beyond Established Risk Predictors in Multivessel Coronary Artery Disease?
    Clin Cardiol. 2026;49:e70410.
    PubMed        
    
    

    
    Eur Heart J

19. KINDBORG G, Eriksson Hogling D, Habel H, Yan J, et al
    Major cardiovascular events in first-degree relatives of individuals with elevated plasma lipoprotein(a): a registry-based cohort study.
    Eur Heart J. 2025 Aug 31:ehaf677. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Heart

20. MANZO-SILBERMAN S
    No pain, no gain? The complexity of ST-elevation myocardial infarction without chest pain.
    Heart. 2026 Jul 6:heartjnl-2026-328573. doi: 10.1136/heartjnl-2026-328573.
    PubMed        
    
    

    
    J Am Coll Cardiol

21. ITCHHAPORIA D, Yancy CW, Rosen SE, Mbakwem AC, et al
    Cardiovascular Health Equity: Time for a New Era of Science, Sociology, and Interventions: Joint Editorial on Behalf of the American College of Cardiology, the American Heart Association, the European Society of Cardiology, and the World Heart Federat
    J Am Coll Cardiol. 2026 Jul 8:S0735-1097(26)05225.
    PubMed        
    
    
22. GUO X, Sun G, Xie Z, Zhou S, et al
    Cardiovascular Health Change Patterns After Multifaceted Antihypertensive Intervention and Cardiovascular Outcomes: A Post Hoc Analysis of CRHCP Trial.
    J Am Coll Cardiol. 2026 Jun 26:S0735-1097(26)06702.
    PubMed         Abstract available
    
    
23. REDDY RK, Spertus JA, Grantham JA, Ahmad Y, et al
    Seeing Clearly: Blinded and Unblinded Evidence for Symptom Benefit After Chronic Total Occlusion Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2026;88:38-41.
    PubMed        
    
    

    
    J Cardiovasc Pharmacol

24. HILVO M, Witoslawska A, Laaperi M, Jylha A, et al
    Ceramide-phospholipid risk score associates with cardiovascular events and is lowered by atorvastatin, simvastatin and anti-PCSK9 treatments.
    J Cardiovasc Pharmacol. 2026 Mar 12. doi: 10.1097/FJC.0000000000001817.
    PubMed         Abstract available
    
    
25. MILAN RR, Jimenez Castellanos MS, Doniz Viveros AD, Yusufzai MO, et al
    Efficacy and safety of CETP inhibitors in patients with atherosclerotic cardiovascular disease: A systematic review and meta-analysis of randomized controlled trials.
    J Cardiovasc Pharmacol. 2026 Jul 6. doi: 10.1097/FJC.0000000000001856.
    PubMed         Abstract available
    
    

    
    J Clin Invest

26. KOENIG AL, Kadyrov FF, Amrute JM, Yang S, et al
    Fate-mapping infiltrating monocytes following experimental myocardial infarction revealsdifferentiation trajectories in the infarcted heart.
    J Clin Invest. 2026 Jul 7:e189684. doi: 10.1172/JCI189684.
    PubMed         Abstract available
    
    

    
    J Mol Cell Cardiol

27. JIE L, Zhou T, Li G, Shen W, et al
    Melatonin promotes coronary angiogenesis and ameliorates cardiac dysfunction after myocardial infarction via endothelial LRRC8A.
    J Mol Cell Cardiol. 2026 Jul 9:S0022-2828(26)00104.
    PubMed         Abstract available
    
    

    
    Mol Cell Biochem

28. XU Z, Yang S, Tan Y, Zhang Q, et al
    Pentraxin 3 is an inflammation-related biomarker that distinguishes early-stage from mid-advanced cardiovascular-kidney-metabolic syndrome.
    Mol Cell Biochem. 2026 Jul 4. doi: 10.1007/s11010-026-05618.
    PubMed         Abstract available
    
    

    
    PLoS One

29. ALIEVA RB, Shek AB, Bahachova AV, Fozilov KG, et al
    Genetic yield of next-generation sequencing for detecting monogenic familial hypercholesterolemia in uzbek patients with coronary artery disease.
    PLoS One. 2026;21:e0353401.
    PubMed         Abstract available
    
    
30. CHAYANOPPARAT P, Siriphiphatcharoen P, Laohabut I, Ruengchaisiwawaith T, et al
    Prevalence and prognostic impact of unrecognized myocardial infarction detected by cardiac magnetic resonance in Thai patients with obesity.
    PLoS One. 2026;21:e0353109.
    PubMed         Abstract available
    
    

    
    Prog Cardiovasc Dis

31. DUAN MJ, Poelman MP, Corpeleijn E, Biesbroek S, et al
    Socioeconomic inequalities in the association between diet quality and incident cardiovascular diseases: A prospective study in the Netherlands.
    Prog Cardiovasc Dis. 2026 Jul 6:S0033-0620(26)00068.
    PubMed         Abstract available
    
    

    
    Thromb Haemost

32. JMEL MA, Bialek EL, Sels M, Kotsyfakis M, et al
    Beyond the Bite: Tick Salivary Proteins Targeting Hemostasis and Inflammation; Implications for Cardiovascular Disease.
    Thromb Haemost. 2026 Jul 8. doi: 10.1055/a-2899-3775.
    PubMed         Abstract available
    
    
33. VON HUNDELSHAUSEN P, Siess W, Weber C
    Bruton Tyrosine Kinase as Therapeutic Target in Cardiovascular Diseases-Executive Summary.
    Thromb Haemost. 2026 Jul 8. doi: 10.1055/a-2886-8670.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum